Buy Now or Regret Later: This Small-Cap Stock Has Big Disruption Potential
Valued at $1.5 billion, Alphatec Holdings (ATEC), a spinal-surgery-focused medtech firm, is one such under-the-radar name that is steadily attracting Wall Street and investor attention. Its products are specifically designed to simplify complex procedures, improve reproducibility, and help surgeons treat spinal conditions more effectively.
More News from Barchart
Opendoor Stock Is Surging Higher in a Frenzied Retail Rally. How Should You Play OPEN Shares Here?
This Penny Stock Wants to Become the MicroStrategy of Dogecoin
Robinhood Stock Stumbles as S&P 500 Inclusion Is Once Again Off the Table for HOOD
Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now!
Alphatec stock has gained 13% year-to-date, compared to the S&P 500 Index's ($SPX) gain of 7.7%. Let's dig in to determine why Alphatec stock is a smart buy now.
Alphatec Is Setting the Stage for More Growth
Alphatec is known for using artificial intelligence (AI) to create advanced, integrated surgical systems that include implants, imaging, navigation, robotics, and biologics. The company's goal is to revolutionize spinal surgery, making it safer and more effective for patients. Some of its innovative approaches include the Anterior/Posterior Cervical Discectomy & Fusion (ACDF/PCF), Lateral, Transforaminal, Anterior Lumbar Interbody Fusion (LTP/TLIF/ALIF), corpectomy systems, and PTP (Prone TransPsoas).
While ATEC is still a small-cap firm, its revenue growth, product adoption, and expanding footprint point to a company writing a strong growth story. In the first quarter, total revenue increased 22% year-over-year to $169 million, along with 24% growth in surgical revenue. The company has developed a loyal base of highly engaged surgeons, and more trained surgeons are adopting ATEC systems. Q2 saw an 18% increase in new surgeon adoption, which is a positive indicator for future growth.
Alphatec is aggressively investing in R&D and surgeon training, affecting short-term profits while increasing long-term value creation. R&D expenses totaled $16.6 million in the first quarter, resulting in a net loss of $51.9 million, or $0.35 per share. However, adjusted gross margin stood at an impressive 70% for the quarter. Alphatec ended the second quarter with $153.2 million in cash and cash equivalents. Its balance sheet is currently strong enough to support growth without excessive dilution.
Various factors, including aging demographics, a shift toward minimally invasive surgical methods, digitization, robotics, and surgeons demanding better tools, could drive the spine surgery market forward. Alphatec has established a strong moat by combining software, hardware, and biologics into a streamlined ecosystem focused solely on spine surgery solutions. Its rapid revenue growth, improving margins, and expanding moat indicate that the company is on track to profitability. CEO Pat Miles believes, 'We are built to lead, and the best is yet to come.'
The company will release its second-quarter earnings on July 31. Analysts expect revenue to rise 22.5% to $178.8 million.
For the full year, analysts project revenue growth of 20%, which is consistent with management's projections, with an additional 18.3% increase in 2026. Alphatec, trading at 2x forward sales, is a reasonable buy for a company with significant growth potential in the spine surgery market.
Is Alphatec Stock a Buy, Hold, or Sell?
The consensus on Alphatec stock is a "Strong Buy.' Of the 11 analysts covering ATEC, nine have rated it a 'Strong Buy,' one recommends a 'Moderate Buy,' and one says it is a 'Hold.' Based on its mean price target of $18.32, Wall Street expects the stock to climb as high as 74% from current levels. Furthermore, its Street-high estimate of $22.50 implies potential upside of nearly 113.6% in the next 12 months.
The Bottom Line on ATEC Stock
The global spine surgery market is massive, valued at more than $14.5 billion and expected to reach $19.1 billion by 2030. Alphatec is a small player in the medtech industry, but its focus on spine surgery solutions gives it a competitive advantage. Given this advantage, it is ahead of the competition.
Alphatec, like most small-cap biotech growth stocks, is highly volatile. However, it remains an excellent choice for those seeking exposure to medical innovation with genuine long-term upside and who are willing to bear the short-term risks.
On the date of publication, Sushree Mohanty did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
3 hours ago
- Miami Herald
Why did stocks tumble this week?
The stock market had a tough week, with the S&P 500 and tech-stock-heavy Nasdaq retreating sharply on Thursday and Friday following a batch of concerning news on inflation, jobs, and tariffs. The S&P 500 fell 2.7% from an early-week high while the Nasdaq lost 3.9% of its value from its peak on Thursday. Here's why stocks retreated, and what could happen next. The stock market sell-off began in earnest following the Federal Reserve's controversial decision to keep interest rates at 4.25% to 4.5%. President Trump has advocated for Fed Chairman Jerome Powell to cut rates aggressively, recommending a 3% reduction. Related: Goldman Sachs revamps Fed interest rate cut forecast for 2025 Lower interest rates support stock prices because they increase household and business spending, fueling revenue and profit growth. Powell's reluctance to lower rates remains a headwind for stocks this year. Powell cited risks of tariffs driving inflation higher later this year and a "solid" economy for the decision to leave rates unchanged. Many viewed his hawkish tone during his press conference as an indication that rates may not get cut at the next meeting in September either. The decision drew the ire of President Donald Trump, who has previously called Chairman Powell "Mr. Too Late" and a "numbskull" for not already reducing interest rates. The President renewed his calls for Powell to resign following the Fed meeting. Despite White House pressure, the Fed's dual mandate targets low unemployment and inflation, which dictates its decisions on monetary policy. The Fed's mandate purposefully excludes political jawboning. Unfortunately, the Fed's dual goals are contradictory. While Fed rate cuts boost economic activity and lower unemployment, they increase inflation. The opposite is true when it raises rates. This dynamic often means that the Fed hesitates for fear of causing more economic problems than it solves. Unfortunately, that often means that the Fed falls behind the curve when setting interest rates at appropriate levels, forcing it to act more aggressively than it might otherwise because the economy has gotten too hot or cold. That chasing can lead to greater uncertainty, causing stock market volatility. The stock market's sell-off earlier in 2025 was primarily due to higher-than-expected import tariffs and the risk that they would boost inflation, zapping economic activity. Those worries fell when President Trump paused many tariffs on April 9, kickstarting a massive stock market rally that sent the S&P 500 and Nasdaq up over 28% and 38%, respectively. More Layoffs: Intel's recent layoffs take an unexpected turnWalmart makes more cuts customers won't likeLooking for a job? Job ads probably won't help you find one However, now that President Trump's tariff pause expired on August 1, he's announced new tariffs ranging from 10% to 41%, including a 35% tariff on Canada, up from 25%. Canada was our third-largest trading partner in 2024. The higher tariffs are problematic, given that they occur even as the impact of tariffs left in place earlier this year seems to be increasing inflation. The Personal Consumption Expenditures index showed inflation increased to 2.6% in June, up from 2.4% in May and 2.2% in April. The higher and faster inflation rises, the more likely business and household spending will shrink, dinging corporate revenue and earnings growth at publicly traded companies. The stock market was also hit by disappointing jobs data. Stocks perform best when the economy creates more jobs and wages grow, creating extra discretionary income. Related: Jobs report shocker resets Fed interest rate cut bets On Friday, the Bureau of Labor Statistics said the US economy only added 73,000 jobs in July, far fewer than the 100,000 expected and 147,000 in June. As a result, the unemployment rate increased to 4.24%, its highest level this cycle. Meanwhile, the Job Openings and Labor Turnover Survey (JOLTS) showed the number of open jobs fell to 7.4 million in June from 7.7 million in May. In case that wasn't concerning enough, Challenger, Gray & Christmas reported that US employers announced 62,075 layoffs in July, up 29% from June and 140% year over year. Stocks have had a remarkable rally, and it's not shocking that they might take a break. August is a notoriously weak month for stock market returns, and recent gains have lifted the S&P 500's forward price-to-earnings ratio, a key valuation measure, to lofty levels. According to FactSet, the S&P 500's forward P/E ratio was 22.4 on Friday, near the highs set in February before tariff announcements caused a sell-off, and up from about 19 in April, when stocks were near the lows. With valuation arguably rich and inflation and jobs uncertainty growing, stocks could experience more volatility than usual this month. Long-term investors are likely best off simply recognizing that pullbacks are common. According to Capital Group, a money manager with $2.2 trillion under management, the S&P 500 retreats 5% to 10% about once per year. Short-term investors may want to take a different approach, locking in recent gains and looking for lower entry points in the coming weeks. Related: Morgan Stanley resets S&P 500 target for 2026 The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Yahoo
6 hours ago
- Yahoo
Some strategists see a stock-market bubble brewing — and it's not the Magnificent 7's fault this time
Stock valuations are rising. Rather than the Mag Seven, look at the "Terrific 20." The Terrific 20 stocks includes diverse sectors, indicating a broadening market beyond Big Tech. But some warn of "speculative fervor," given that price multiples, not earnings, are on the rise. Stock valuations are getting frothy again, but this time, it's not all Big Tech's fault. Yes, valuations of the Magnificent Seven stocks — Apple, Amazon, Microsoft, Meta, Alphabet, Nvidia, and Tesla — are back up after since bottoming in April. Yet, the group's 12-month forward price-to-earnings ratio is still down from mid-2024, mid-2023, and 2020 levels. Meanwhile, forward PE ratios on the next 20 stocks in the S&P 500 continue to surge, topping levels seen earlier this year. Their valuations are also higher than at any point over the last decade. Arun Sai, a senior multi-asset strategist at Pictet Asset Management, calls the group the "Terrific 20." Some may see the rising forward expectations for a widening number of stocks as a sign of health, as the rally extends beyond just the most popular stocks. But when stocks rise because of multiple expansion instead of earnings growth, it may be a sign that investor sentiment is becoming overheated. "These companies span a broad set of sectors more closely tied to the real economy, including financials, energy, industrials, consumer, and legacy tech," Sai wrote on Tuesday. "Names like Broadcom, Walmart, JPMorgan, Berkshire Hathaway, Visa, and GE Aerospace now account for ~17% of the MSCI US index, compared to 33% for the Mag 7." "Broader participation is a positive — when it's driven by earnings," he continued. "But when more of the market gets expensive, the narrative that 'US equities aren't overpriced, just a few exceptional companies are' becomes harder to justify." Sai compared the current environment to the so-called "Nifty Fifty" bubble in the 1960s. Richard Bernstein, the founder of Richard Bernstein Advisors and former chief investment strategist at Merrill Lynch, said in June that there are parallels to another famous episode of euphoria—the dot-com bubble of 2000—as the market seems solely focused on an emerging technology. On Wednesday, Bernstein reiterated his skepticism of the rally, noting that the market is still relatively concentrated even if valuations are surging among more than just the top seven stocks. Trading of leveraged ETFs, zero-day options, and low dollar-value stocks is also picking back up, signs of excess optimism, he said. "If you're a trader, I think you should take a deep breath and kind of look at what's going on and realize that everybody's in this huge speculative fervor," Bernstein told Business Insider. "But if you're an investor and you want to be a little patient, I don't think it gets much better than this." "The reckless abandon is going to leave you with so many opportunities," he continued. "It's going to be like post-2000." Most Wall Street strategists don't see a dramatic pullback ahead, and few have made direct comparisons to prior bubble episodes. In recent days, however, some have extended quiet warnings to investors about the market's near-term direction. Ulrike Hoffmann-Burchardi, CIO Americas and global head of equities at UBS Global Wealth Management, said in a note on Tuesday that "investors should be mindful of potential market swings in the coming weeks," and that "capital preservation or phasing-in strategies can be effective in navigating near-term volatility." While valuations are no doubt extended, there's no guarantee a major market top is near, and the AI trade may have room to run as the technology evolves. Meta and Microsoft, for example, reported strong earnings beats this week and gave positive forward guidance, causing shares to soar. Read the original article on Business Insider Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 hours ago
- Yahoo
Some strategists see a stock-market bubble brewing — and it's not the Magnificent 7's fault this time
Stock valuations are rising. Rather than the Mag Seven, look at the "Terrific 20." The Terrific 20 stocks includes diverse sectors, indicating a broadening market beyond Big Tech. But some warn of "speculative fervor," given that price multiples, not earnings, are on the rise. Stock valuations are getting frothy again, but this time, it's not all Big Tech's fault. Yes, valuations of the Magnificent Seven stocks — Apple, Amazon, Microsoft, Meta, Alphabet, Nvidia, and Tesla — are back up after since bottoming in April. Yet, the group's 12-month forward price-to-earnings ratio is still down from mid-2024, mid-2023, and 2020 levels. Meanwhile, forward PE ratios on the next 20 stocks in the S&P 500 continue to surge, topping levels seen earlier this year. Their valuations are also higher than at any point over the last decade. Arun Sai, a senior multi-asset strategist at Pictet Asset Management, calls the group the "Terrific 20." Some may see the rising forward expectations for a widening number of stocks as a sign of health, as the rally extends beyond just the most popular stocks. But when stocks rise because of multiple expansion instead of earnings growth, it may be a sign that investor sentiment is becoming overheated. "These companies span a broad set of sectors more closely tied to the real economy, including financials, energy, industrials, consumer, and legacy tech," Sai wrote on Tuesday. "Names like Broadcom, Walmart, JPMorgan, Berkshire Hathaway, Visa, and GE Aerospace now account for ~17% of the MSCI US index, compared to 33% for the Mag 7." "Broader participation is a positive — when it's driven by earnings," he continued. "But when more of the market gets expensive, the narrative that 'US equities aren't overpriced, just a few exceptional companies are' becomes harder to justify." Sai compared the current environment to the so-called "Nifty Fifty" bubble in the 1960s. Richard Bernstein, the founder of Richard Bernstein Advisors and former chief investment strategist at Merrill Lynch, said in June that there are parallels to another famous episode of euphoria—the dot-com bubble of 2000—as the market seems solely focused on an emerging technology. On Wednesday, Bernstein reiterated his skepticism of the rally, noting that the market is still relatively concentrated even if valuations are surging among more than just the top seven stocks. Trading of leveraged ETFs, zero-day options, and low dollar-value stocks is also picking back up, signs of excess optimism, he said. "If you're a trader, I think you should take a deep breath and kind of look at what's going on and realize that everybody's in this huge speculative fervor," Bernstein told Business Insider. "But if you're an investor and you want to be a little patient, I don't think it gets much better than this." "The reckless abandon is going to leave you with so many opportunities," he continued. "It's going to be like post-2000." Most Wall Street strategists don't see a dramatic pullback ahead, and few have made direct comparisons to prior bubble episodes. In recent days, however, some have extended quiet warnings to investors about the market's near-term direction. Ulrike Hoffmann-Burchardi, CIO Americas and global head of equities at UBS Global Wealth Management, said in a note on Tuesday that "investors should be mindful of potential market swings in the coming weeks," and that "capital preservation or phasing-in strategies can be effective in navigating near-term volatility." While valuations are no doubt extended, there's no guarantee a major market top is near, and the AI trade may have room to run as the technology evolves. Meta and Microsoft, for example, reported strong earnings beats this week and gave positive forward guidance, causing shares to soar. Read the original article on Business Insider Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
